Great Bay Bio Closes Nearly USD10M Series A Funding

Great Bay Bio, a Hong Kong-based high-tech enterprise dedicated to applying artificial intelligence and other technologies in CMC bioprocessing, completed a near USD10M Series A funding. The round was led by Proxima Ventures with participation from many new and existing institutional investors.

Read more: https://bit.ly/3lxkAbJ

AI drug discovery booms in China

Chinese upstart companies and IT goliaths hope to turn countrys artificial intelligence prowess into world-leading drug innovation. Do they have an edge over Western players? Chinese researchers are abuzz about the potential of artificial intelligence (AI) in drug design and development.

Read more: https://go.nature.com/3rWmiFE

港初創AI平台加速藥物研發

原文刊於信報財經新聞「StartupBeat創科鬥室」 由Alex Zhavoronkov創立的Insilico Medicine,主打可應用於藥物研發的AI技術。(Insilico Medicine圖片) 香港生物科技研發成果經常揚威海外,吸引不少生物科技初創來港落戶,Insilico Medicine就

Read more: https://bit.ly/3i5Ou2g

星Gero籌1716萬 AI覓抗衰老療法

原文刊於信報財經新聞「StartupBeat創科鬥室」 Peter Fedichev(中)表示,利用藥物延長人類壽命並非新鮮事。(Gero圖片) 新加坡生物科技初創Gero近日獲得A輪融資,成功籌得220萬美元(約1716萬港元),由Bulba Ventures領投。新資金

Read more: https://bit.ly/2DzFSCJ

Proudly powered by WordPress | Theme: Baskerville 2 by Anders Noren.

Up ↑